Category: Uncategorized

Curapath receives representatives of the Valencian Generalitat in their facilities at the Valencia technology park

Paterna, May 9, 2025 – Curapath, a global life sciences company specializing in the custom design, development, and manufacturing of advanced drug delivery systems, yesterday welcomed an institutional visit from Felipe Carrasco, Regional Secretary of Industry, Commerce, and Consumer Affairs, and Rafael Escamilla, Director of External Relations at IVACE, at

READ MORE »

Curapath, working towards equity and inclusive development, is pleased to announce the approvement and publishment of its Gender Equality Plan (GEP)

November 21, 2024, Valencia, Spain, At Curapath, we believe that a fair, inclusive, and diverse workplace is the foundation for innovation and collective well-being. In alignment with this belief, we are proud to announce the official approval and publication of our Gender Equality Plan (GEP), a key milestone that reinforces

READ MORE »
CERTEST

Curapath & Certest Join Forces to Offer Next-Generation Lipid Nanoparticles (LNP) Formulations with Proprietary Excipients

VALENCIA & ZARAGOZA, SPAIN, 07 OCT 2024. Curapath, a leading innovator in the manufacturing of novel lipid and polymer excipients, nanoparticle formulations and innovative polymer conjugates, and Certest Biotech, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with Lipid Nanoparticles (LNPs) and Active Pharmaceutical

READ MORE »

Curapath Appoints Philippe Clavel as Chief Executive Officer

Curapath, a developer, manufacturer, and formulator of lipid- and polymer-based nanoparticles used in advanced therapeutic delivery technology, today announced the appointment of Philippe Clavel as Chief Executive Officer. Curapath is a portfolio company of Arcline Investment Management. Philippe has previously held leadership positions in the pharmaceutical and biotechnology industries. Most recently, he

READ MORE »

Curapath Receives Accreditation as a GMP Investigational Drug Product Manufacturer from the Spanish Agency for Medicine and Health Products

Valencia, Spain and Boston, MA, January 26, 2023 – Curapath, a leader in the design, development, andcustom manufacturing of polyamino-acid- and lipid nanoparticle (LNP) delivery systems for therapeuticsand vaccines, today announced the company has received accreditation as a GMP investigational drugproduct manufacturer from the Spanish Agency for Medicine and Health Products

READ MORE »

Curapath Announces Collaboration with Afrigen Biologics to Advance Development of African-owned mRNA SARS-CoV-2 Vaccine

Curapath will develop and optimize a process to produce a nanoparticle formulation for the vaccine Valencia, Spain and Boston, MA, November 16, 2022 – Curapath, a leader in the design, development, and custom manufacturing of polyamino-acid- and lipid-based nanoparticle delivery systems for therapeutics and vaccines, today announced a collaboration with

READ MORE »